Dietary Safflower Oil and Cardiometabolic Health: From Molecular Mechanisms to Clinical Implications

Metabolic syndrome, characterised by central obesity, dyslipidemia, hypertension, and insulin resistance, continues to rise globally, presenting substantial health risks. Dietary interventions are increasingly investigated as complementary approaches for managing these metabolic disturbances, with safflower (Carthamus tinctorius L.) emerging as a promising candidate due to its rich content of polyunsaturated fatty acids, particularly linoleic acid, and bioactive flavonoids. This review systematically examines current evidence regarding the biochemical, physiological, and clinical impacts of safflower-derived oils and petal extracts on cardiometabolic health. Experimental studies demonstrate that linoleic acid-rich safflower oil can modulate lipid profiles, reduce circulating triglycerides and LDL cholesterol, and enhance hepatic lipid metabolism, while safflower petal extracts influence glucose homeostasis via the AKT/FoxO1 signalling pathway and exert anti-inflammatory effects through NF-κB and Nrf2 modulation. Additionally, emerging research highlights safflower’s interaction with the gut microbiota, promoting beneficial bacterial populations and regulating metabolite-mediated hepatic glucose production. Despite these benefits, variability in study outcomes is noted, influenced by differences in oil composition, dosage, intervention duration, and metabolic context. Comparisons with other lipid sources indicate that safflower oil provides metabolic advantages over saturated fats, yet omega-3-rich oils may offer superior anti-inflammatory and muscle-preserving effects. Overall, the integration of biochemical, animal, and human clinical data underscores the potential of safflower as a context-specific nutritional intervention for metabolic syndrome. Future research should focus on optimizing formulations, understanding gut-liver interactions, and evaluating long-term clinical efficacy to establish evidence-based dietary strategies that leverage safflower’s unique bioactive profile.

Authors

Institutions

Publication Details

Journal
Journal of international research in medical and pharmaceutical sciences
Published
2026-04-01
DOI
https://doi.org/10.56557/jirmeps/2026/v21i210417
Primary Topic
Sunflower and Safflower Cultivation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dietary Safflower Oil and Cardiometabolic Health: From Molecular Mechanisms to Clinical Implications

Uday Kiran Bathini, Naresh Vallakati, Terry L. Oroszi
Journal of international research in medical and pharmaceutical sciences
Sunflower and Safflower Cultivation
article

Dietary Safflower Oil and Cardiometabolic Health: From Molecular Mechanisms to Clinical Implications

Uday Kiran Bathini, Naresh Vallakati, Terry L. Oroszi
article en

Abstract

Metabolic syndrome, characterised by central obesity, dyslipidemia, hypertension, and insulin resistance, continues to rise globally, presenting substantial health risks. Dietary interventions are increasingly investigated as complementary approaches for managing these metabolic disturbances, with safflower (Carthamus tinctorius L.) emerging as a promising candidate due to its rich content of polyunsaturated fatty acids, particularly linoleic acid, and bioactive flavonoids. This review systematically examines current evidence regarding the biochemical, physiological, and clinical impacts of safflower-derived oils and petal extracts on cardiometabolic health. Experimental studies demonstrate that linoleic acid-rich safflower oil can modulate lipid profiles, reduce circulating triglycerides and LDL cholesterol, and enhance hepatic lipid metabolism, while safflower petal extracts influence glucose homeostasis via the AKT/FoxO1 signalling pathway and exert anti-inflammatory effects through NF-κB and Nrf2 modulation. Additionally, emerging research highlights safflower’s interaction with the gut microbiota, promoting beneficial bacterial populations and regulating metabolite-mediated hepatic glucose production. Despite these benefits, variability in study outcomes is noted, influenced by differences in oil composition, dosage, intervention duration, and metabolic context. Comparisons with other lipid sources indicate that safflower oil provides metabolic advantages over saturated fats, yet omega-3-rich oils may offer superior anti-inflammatory and muscle-preserving effects. Overall, the integration of biochemical, animal, and human clinical data underscores the potential of safflower as a context-specific nutritional intervention for metabolic syndrome. Future research should focus on optimizing formulations, understanding gut-liver interactions, and evaluating long-term clinical efficacy to establish evidence-based dietary strategies that leverage safflower’s unique bioactive profile.

Journal of international research in medical and pharmaceutical sciencesVol. 21(2)
Boonshoft Museum of Discovery (US)
Zero hunger
Openalex Percentile: Top 36%
Sunflower and Safflower Cultivation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.